Platform Partnerships 4D's MicroRx platform enables rational discovery of live biotherapeutics, presenting opportunities to partner with other pharma to co-develop LBPs or license discovery capabilities for new indications or vaccines.

Proven Collaborations With ongoing collaboration with MSD and vaccine discovery work, 4D Pharma demonstrates credible capabilities in microbiome therapeutics, making it a compelling partner for external R&D collaborations, co development, or licensing.

CRO and CMO As a small clinical stage company with limited revenue, 4D Pharma could be a strong candidate for outsourced development and manufacturing services to advance live biotherapeutic programs, including preclinical to early clinical manufacturing, quality systems, and regulatory support.

Patient Engagement The Parkinson’s UK Patient Advisory Board initiative signals emphasis on patient-centric trial design and recruitment, suggesting opportunities to offer patient recruitment, advisory board services, and real world data partnerships to help sponsors running LBP trials.

Asset Strategy Recent asset movements with CJ Bioscience indicate potential opportunities around asset monetization, licensing, or transition services for LBP candidates, providing avenues to engage CJ or the seller for licensing deals, data access, or continuity partnerships.